about
Tissue MicroArray (TMA) analysis of normal and persistent Chlamydophila pneumoniae infectionA comparative ultrastructural and molecular biological study on Chlamydia psittaci infection in alpha-1 antitrypsin deficiency and non-alpha-1 antitrypsin deficiency emphysema versus lung tissue of patients with hamartochondromaDetermination of PCR efficiency in chelex-100 purified clinical samples and comparison of real-time quantitative PCR and conventional PCR for detection of Chlamydia pneumoniaeCurrent problems of perinatal Chlamydia trachomatis infectionsChlamydia pneumoniae is genetically diverse in animals and appears to have crossed the host barrier to humans on (at least) two occasionsThe Chlamydia psittaci genome: a comparative analysis of intracellular pathogensAssociation of Chlamydia pneumoniae Infection With Atherosclerotic Plaque FormationInhibition of PCR in genital and urine specimens submitted for Chlamydia trachomatis testing.Prevalence of specific antibodies to Chlamydia pneumoniae in KoreaThe antithrombotic factor singlet oxygen/light (1O2/h nu).Immunopathogenic consequences of Chlamydia trachomatis 60 kDa heat shock protein expression in the female reproductive tractIs asthma an infectious disease? New evidence.Chlamydia trachomatis prevalence in men in the mid-west of Ireland.Prevalence of antibodies to Chlamydia pneumoniae in an Israeli population without clinical evidence of respiratory infection.T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.Chlamydia trachomatis: genome sequence analysis of lymphogranuloma venereum isolatesMultiplex polymerase chain reaction for the simultaneous detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Chlamydia psittaci in respiratory samples.In vitro activity of a partially purified and characterized bark extract of Castanea sativa Mill. (ENC®) against Chlamydia spp.Chlamydia trachomatis serotype A infections in the Amazon region of Brazil: prevalence, entry and dissemination.The chlamydial anomaly clarified?Prevalence of Chlamydophila psittaci infections in the eyes of cattle, buffaloes, sheep and goats in contact with a human population.Impact of free-living amoebae on presence of Parachlamydia acanthamoebae in the hospital environment and its survival in vitro without requirement for amoebaeNovel Parachlamydia acanthamoebae quantification method based on coculture with amoebae.Associations between Chlamydophila infections, schizophrenia and risk of HLA-A10.Activity of cathelicidin peptides against Chlamydia spp.Single-run, parallel detection of DNA from three pneumonia-producing bacteria by real-time polymerase chain reaction.Distribution of Chlamydia pneumoniae DNA in atherosclerotic carotid arteries: significance for sampling procedures.Chlamydia pneumoniae infection induces differentiation of monocytes into macrophages.Low iron availability modulates the course of Chlamydia pneumoniae infection.Characterization and intracellular trafficking pattern of vacuoles containing Chlamydia pneumoniae in human epithelial cells.Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity.Dynamics of the development of Chlamydophila psittaci inclusions in epithelial and fibroblast host cells.Chlamydia pneumoniae in a free-ranging giant barred frog (Mixophyes iteratus) from Australia.Chlamydia trachomatis: The persistent pathogen.Atypical bacteria and macrolides in asthmaSeroprevalence of Chlamydophila Psittaci among Employees of Two German Duck Farms.Quality improvement interventions for improving the detection and management of curable sexually transmitted infections in primary care
P2860
Q21261768-794913FC-E34B-4F3C-B64A-222F31B6BAA5Q24797013-3B84A15E-EE08-463A-B966-3AD12EBA624AQ24798213-B661955D-6421-4E44-A03A-B8217861021CQ24801543-0159B76E-EC48-4131-A4E9-B7E07F5826EBQ27314770-0A54DC2C-41B0-4EA9-A714-7DB7D04580ACQ28730662-60BE5EAE-6850-438D-84A9-C336CD574CDAQ28833753-A179FA43-8212-465D-B16A-C8A385CA02EBQ33676833-0565EF3D-B917-453C-BC8C-D7AEEC1AB9F0Q33688588-69DA4143-77F0-4996-A4D1-9EC2F9CEF71AQ33868363-398B3082-B80C-4DA9-8098-00F1204F73D7Q34427550-B4C34ED9-109B-4BC9-93F9-2543929E979FQ35007596-C673A903-5728-410B-9067-CBDD5E9986F6Q35531472-6286291D-FECA-4C0D-8653-2C98F0C953A4Q35586164-932CB3DD-D6BE-427D-85B2-21A074579F72Q35839422-178EF832-83A3-4F4A-A952-745171B8B27BQ36259301-DED1CE5C-63E9-49BC-87AA-CB2C1CE438F3Q37236246-C164B2F5-6430-47BD-A460-D1DF700BD9CBQ37834775-2A524FE4-5581-41A0-8A64-3150ABFE8D44Q37840554-4AD5AC11-55F6-4AEF-8464-56DD73252B3AQ37844236-0B94E4ED-DF99-40B3-A408-5E8CB9FC5B64Q37848819-CB024FA1-F7C9-46C3-94E2-3A45AC0E5471Q37852686-EEC0E5A5-229D-4257-80C4-12815C461168Q37856695-02160865-FD6B-41A8-BB9F-E767EED12385Q37860923-CAECD834-264A-4BD8-9075-7F18E817F278Q37865416-84D9E8D8-42B5-41F5-B69D-615BDFDE6C23Q37865603-0AAAE4CC-6E0F-41E2-9176-A64CB1E991A5Q37869629-D0FB139C-4434-4BED-B0D4-35F61FEE8D3BQ37872148-89BBA9D3-1DDC-4E1A-91C3-5E78AFA63E9CQ37873990-3315BE1B-5BD9-402D-8971-55B0C05D2E30Q37874935-E5491610-BCEE-4ED7-9F6A-A4393A9127E4Q37875477-5DFEB935-13EC-4713-8E1C-E4ED6A7BC0D7Q37876055-DF8F0DA7-DEAF-422F-99BB-210DBD417D32Q37878264-770CA4DE-A40B-46A6-89F3-030A1DB7BEEDQ40082116-6D652B7F-5617-467B-BA97-F9A87283113DQ40518030-01FFF6B0-E03C-4534-A0D8-3AD19B8F9CA7Q49187436-B8F6D05E-DB16-4B7A-8572-983E0CD5BB40Q58901247-77A3D270-B5F0-4C27-A87C-A990AAF18908
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Chlamydiae as pathogens: new species and new issues.
@en
type
label
Chlamydiae as pathogens: new species and new issues.
@en
prefLabel
Chlamydiae as pathogens: new species and new issues.
@en
P2860
P921
P356
P1476
Chlamydiae as pathogens: new species and new issues.
@en
P2093
Brunham RC
Peeling RW
P2860
P304
P356
10.3201/EID0204.960406
P577
1996-10-01T00:00:00Z